Drug search by name

Tranylcypromine and Parkinsonism

Result of checking the interaction of drug Tranylcypromine and disease Parkinsonism for safety when used together.

Check result:

Tranylcypromine <> Parkinsonism

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Nonspecific monoamine oxidase inhibitors (MAOIs) may increase the frequency and severity of signs and symptoms associated with parkinsonian syndrome. Therapy with nonspecific MAOIs should be administered cautiously in patients with this disorder.

References:

Teusink JP, Alexopoulos GS, Shamoian CA "Parkinsonian side effects induced by a monoamine oxidase inhibitor." Am J Psychiatry 141 (1984): 118-9
"Product Information. Parnate (tranylcypromine)." SmithKline Beecham, Philadelphia, PA.
Gillman MA, Sandyk R "Parkinsonism induced by a monoamine oxidase inhibitor." Postgrad Med J 62 (1986): 235-6
"Product Information. Marplan (isocarboxazid)" Roche Laboratories, Nutley, NJ.
"Product Information. Nardil (phenelzine)." Parke-Dvis, Morris Plains, NJ.

Tranylcypromine

Generic Name: tranylcypromine

Brand Name: Parnate

Synonyms: n.a.

What is Tranylcypromine?